Top Verily leaders depart amid reorganization, layoffs; will America’s public health reckoning ever come?

Health tech company Verily announced Wednesday that it is restructuring its management team and business and cutting 15% of its workforce. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: Top Verily executives depart amid leadership shakeup and layoffs By Matthew Herper Sipa via AP Read the memo from Verily CEO Stephen Gillett announcing layoffs and a reorganization at the Alphabet life sciences spinout. Read More Will America's public health reckoning ever come? By Rachel Cohrs Win McNamee/Getty Images Despite the failures of the Covid response, very little about U.S. pandemic infrastructure has changed. But some are working to find reforms. Read More Scientists are finding increasing evidence for a link between air pollution and neurodegenerative diseases like Alzheimer's By Lauren Gravitz Maria Fabrizio for STAT Scientists are finding increasing evidence for a link between air pollution and neurodegenerative diseases like Alzheimer's and Parkinson's. Read More Sponsored Insight by STAT+ You're invited to STAT's JPM Recap On Jan. 13, get a full rundown of the deals, data, and scuttlebutt from the STAT reporters who attended the conference, and come away with insights you won't get anywhere else. Sign up here. What's standing in the way of wastewater data becoming a more mainstream public health tool By Brittany Trang Adobe The pandemic paved the way for a national system to monitor wastewater for disease spread. There are hurdles to using it more broadly. Read More Lawmakers again urge the Biden administration to use federal law to widen access to a cancer drug By Ed Silverman Kevin Dietsch/Getty Images Last month, the National Institutes of Health offered a vague timeline for addressing the march-in rights petition filed by cancer patients. Read More Opinion: Another Ebola outbreak, another missed opportunity for preparedness By Swati Gupta Hajarah Nalwadda/AP The world needs a stockpile of candidate vaccines that are available to be tested during outbreaks of Ebola, Nipah, and other diseases. Read More STAT+: Upstart Element ratchets up race for cheaper DNA sequencing with a $200 genome By Jonathan Wosen Adobe Element’s machine can now read a whole human genome for as little as $200 — the cost of a couple trips to the grocery store. Read More STAT+: HHS will seek more input on its new Medicare drug price negotiations By Rachel Cohrs Chris Carlson/AP HHS laid out a detailed timeline of when the public can weigh on on the agency’s new Medicare drug price negotiation program. Read More Wednesday, January 11, 2023       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2023, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser